Beurs-watcher schreef op 26 januari 2019 14:27:
[...]
Dan kan ik maar één conclusie trekken en dat is dat je je van te voren niet goed hebt verdiept in Pharming Group.
En dat is echt bij Biotech wel een vereiste of je moet een gokker zijn.
Wat Pharming jou wil laten weten is aan Pharming zelf en voor de rest kan ik je verwijzen naar:
Communication with Shareholders
We communicate with our Shareholders and investors through the publication of the annual Report, meetings of shareholders, press releases and our website. Pharming organises analysts and press meetings and/or conference calls, when presenting half year and annual financial results
or other significant news. These meetings and/or conference calls are announced in advance by means of press releases and on Pharming´s website. Audio and/or webcasts of these conferences calls and corporate presentations are made available on the website.
In addition to the scheduled half-yearly and yearly result presentations, we maintain regular contact with financial analysts and institutional investors through meetings and roadshows. We regularly present at conferences and corporate and scientific presentations materials for which are also made available on our website.
If you need information other than presented here, please contact our Investor Relations department.
Please contact us at:
T: +31 (0)71 52 47 400
E:
investor@pharming.com